Predisposing factor, impactful adjunctive treatment or unfavorable prognostic marker: a meta-analysis on the elusive role of dexamethasone for Listeria monocytogenes meningitis

Authors

  • Alberto Enrico Maraolo First Division of Infectious Diseases, Cotugno Hospital, Naples, Italy https://orcid.org/0000-0002-7218-7762
  • Maria Mazzitelli Department of Molecular Medicine, Infectious and Tropical Diseases Unit, Padua University Hospital, Padua, Italy

DOI:

https://doi.org/10.3855/jidc.18804

Keywords:

dexamethasone, meta-analysis, neurolisteriosis, therapy, steroid, systematic review

Abstract

Introduction: There are no randomized controlled trials to inform the choice of using adjunctive dexamethasone (AD) against Listeria monocytogenes meningitis (LMM) and data from observational studies are pretty conflicting.

Methodology: We performed a rapid review of the literature with quantitative analysis. A pairwise random-effects meta-analysis was implemented, pooling unadjusted and adjusted data. The main outcome was mortality.

Results: Across all included studies (five) informing the main analysis on raw mortality data, 199 patients received AD, as opposed to 382 who did not receive AD. All-cause mortality was slightly lower in patients undergoing AD, but not in a statistically significant manner: odds ratio 0.96, 95% confidence interval 0.42-2.19. The prediction interval was very wide (0.06-15.99), suggesting that in future studies the effect of AD might be either beneficial or harmful.

Conclusions: The role of AD for LMM still needs to be established being the current evidence inconclusive and heterogeneous.

Downloads

Published

2023-12-31

How to Cite

1.
Maraolo AE, Mazzitelli M (2023) Predisposing factor, impactful adjunctive treatment or unfavorable prognostic marker: a meta-analysis on the elusive role of dexamethasone for Listeria monocytogenes meningitis. J Infect Dev Ctries 17:1748–1752. doi: 10.3855/jidc.18804

Issue

Section

Original Articles